Research Article
TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer
Table 1
Univariate/multivariate cox regression analysis for hub genes.
| Gene | Univariate analysis | Multivariate analysis | HR | 95% CI | value | HR | 95% CI | value |
| TPX2 | 1.032 | 1.025–1.038 | 1.96E − 20 | 1.035 | 1.025–1.045 | 6.07E − 13 | TSPYL5 | 1.043 | 1.024–1.063 | 6.20E − 06 | 1.034 | 1.007–1.061 | 0.013 | CENPF | 1.060 | 1.038–1.082 | 2.24E − 08 | 1.044 | 0.975–1.117 | 0.217 | ASPM | 1.193 | 1.119–1.273 | 7.84E − 08 | 0.921 | 0.744–1.140 | 0.450 | DLGAP5 | 1.082 | 1.050–1.116 | 3.54E − 07 | 1.035 | 0.965–0.110 | 0.340 | CDC20 | 1.009 | 1.004–1.013 | 1.13E − 04 | 0.998 | 0.990–1.006 | 0.680 | KIF20A | 1.036 | 1.017–1.056 | 1.87E − 04 | 0.982 | 0.945–1.021 | 0.357 | NCAPG2 | 1.120 | 1.054–1.190 | 2.55E − 04 | 1.020 | 0.898–1.160 | 0.758 | CCNB2 | 1.026 | 1.009–1.058 | 2.16E − 03 | 1.000 | 0.964–1.038 | 0.989 | PBK | 1.035 | 1.012–1.058 | 2.33E − 03 | 0.992 | 0.952–1.035 | 0.726 | PTTG1 | 1.012 | 1.003–1.020 | 5.23E − 03 | 1.001 | 0.985–1.021 | 0.922 | MELK | 1.033 | 1.009–1.058 | 6.09E − 03 | 0.947 | 0.873–1.027 | 0.186 | ARMCX1 | 1.040 | 1.011–1.070 | 6.69E − 03 | 0.984 | 0.939–1.032 | 0.509 | ECT2 | 1.016 | 1.003–1.028 | 0.012 | 0.992 | 0.955–1.032 | 0.701 | CEP55 | 1.033 | 1.006–1.060 | 0.015 | 1.011 | 0.963–1.062 | 0.647 | BIRC5 | 1.005 | 1.000–1.010 | 0.039 | 0.997 | 0.987–1.007 | 0.610 | CDO1 | 1.050 | 0.998–1.106 | 0.060 | 0.995 | 0.930–1.065 | 0.885 | SFN | 1.000 | 0.998–1.000 | 0.119 | 1.003 | 0.999–1.001 | 0.864 | RRM2 | 1.009 | 0.997–1.021 | 0.138 | 1.003 | 0.985–1.021 | 0.770 | TOP2A | 1.002 | 0.999–1.005 | 0.164 | 1.000 | 0.992–1.008 | 0.977 | ENPP2 | 1.010 | 0.990–1.030 | 0.321 | 1.011 | 0.988–1.035 | 0.350 | MMP12 | 0.996 | 0.984–1.009 | 0.595 | 0.995 | 0.981–1.009 | 0.485 | CYP1B1 | 1.003 | 0.984–1.023 | 0.737 | 1.004 | 0.980–1.028 | 0.755 | TCEAL2 | 1.003 | 0.983–1.024 | 0.743 | 0.994 | 0.970–1.020 | 0.662 |
|
|
HR: hazard ratio; CI: confidence interval.
|